P/Il L Partners Bvf

Affiliations

  • Other at 4D Molecular Therapeutics Inc. (FDMT), 2024-11-13
  • Other at Third Harmonic Bio Inc. (THRD), 2024-10-31
  • Large Shareholder at Eledon Pharmaceuticals Inc. (ELDN), 2024-10-31
  • Large Shareholder, Director at Moonlake Immunotherapeutics (MLTX), 2024-10-08
  • Director, Other at Kymera Therapeutics Inc. (KYMR), 2024-08-22
  • Large Shareholder, Director at Olema Pharmaceuticals Inc. (OLMA), 2024-06-18
  • Director, Other at Rain Oncology Inc. (RAIN), 2024-01-30
  • Large Shareholder at Allakos Inc. (ALLK), 2024-01-26
  • Other at Point Biopharma Global Inc. (PNT), 2023-12-20
  • Large Shareholder at Repare Therapeutics Inc. (RPTX), 2023-11-17
  • Large Shareholder at Engene Holdings Inc. (ENGN), 2023-11-13
  • Large Shareholder, Director, Other at Cti Biopharma Corp (CTIC), 2023-06-28
  • Large Shareholder at Pieris Pharmaceuticals Inc. (PIRS), 2023-05-22
  • Large Shareholder, Director, Other at Xoma Corp (XOMA), 2023-05-19
  • Large Shareholder at Structure Therapeutics Inc. (GPCR), 2023-05-13
  • Large Shareholder at Cullinan Oncology Inc. (CGEM), 2023-01-19
  • Large Shareholder at Essa Pharma Inc. (EPIX), 2022-07-21
  • Large Shareholder at Verastem Inc. (VSTM), 2022-02-08
  • Large Shareholder at Merus N.v. (MRUS), 2021-10-09
  • Large Shareholder at Five Prime Therapeutics Inc. (FPRX), 2021-03-08
  • Other at Infinity Pharmaceuticals Inc. (INFI), 2021-02-19
  • Other at Cytomx Therapeutics Inc. (CTMX), 2021-02-19
  • Other at Ideaya Biosciences Inc. (IDYA), 2021-02-04
  • Other at Cytokinetics Inc (CYTK), 2020-12-11
  • Large Shareholder at Glycomimetics Inc (GLYC), 2020-11-06
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2020-08-20
  • Large Shareholder at Calithera Biosciences Inc. (CALA), 2020-05-26
  • Large Shareholder at Concert Pharmaceuticals Inc. (CNCE), 2019-06-12
  • Large Shareholder at Immune Design Corp. (IMDZ), 2018-12-05
  • Large Shareholder at Syndax Pharmaceuticals Inc (SNDX), 2018-06-20
  • Large Shareholder at Arqule Inc (ARQL), 2018-06-01
  • Large Shareholder at Xenon Pharmaceuticals Inc. (XENE), 2018-03-29
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2017-11-27
  • Other at Capstone Therapeutics Corp. (CAPS), 2017-07-18
  • Large Shareholder at Nivalis Therapeutics Inc. (NVLS), 2017-06-22
  • Large Shareholder at Cascadian Therapeutics Inc. (ONTY), 2016-06-27
  • Other at Chemocentryx Inc. (CCXI), 2015-11-05
  • Other at Catalyst Biosciences Inc. (TRGT), 2015-08-21
  • Other at Array Biopharma Inc (ARRY), 2014-07-10
  • Other at Ligand Pharmaceuticals Inc (LGND), 2014-03-26
  • Other at Regado Biosciences Inc (RGDO), 2014-03-25
  • Large Shareholder at Palatin Technologies Inc (PTN), 2014-03-03
  • Large Shareholder at Rigel Pharmaceuticals Inc (RIGL), 2013-11-20
  • Other at Neurocrine Biosciences Inc (NBIX), 2012-02-10
  • Other at Kent International Holdings Inc (KENT), 2011-12-29
  • Large Shareholder at Icagen Inc (ICGN), 2011-09-09
  • Large Shareholder at Celera Corp (CRA), 2011-05-17
  • Large Shareholder at Supergen Inc (SUPG), 2010-04-21
  • Large Shareholder at Facet Biotech Corp (FACT), 2010-02-09
  • Large Shareholder at Combinatorx Inc (CRXX), 2009-12-24
  • Large Shareholder at Avigen Inc (AVGN), 2009-11-20
  • Large Shareholder at Neurobiological Technologies Inc (NTII), 2009-10-23
  • Large Shareholder at Adolor Corp (ADLR), 2009-09-24
  • Large Shareholder at Dynavax Technologies Corp (DVAX), 2009-09-11
  • Large Shareholder, Other at Repligen Corp (RGEN), 2009-07-08
  • Large Shareholder, Other at Curis Inc (CRIS), 2009-04-29
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ELDN $0.00 75,431 Large Shareholder 220,460 2024-05-09 Filing
ELDN $0.00 821,121 Large Shareholder 2,633,679 2024-05-09 Filing
ELDN $0.00 1,031,385 Large Shareholder 3,361,803 2024-05-09 Filing
RPTX $5.38 16,143 Large Shareholder 548,938 2023-11-16 Filing
RPTX $5.38 125,909 Large Shareholder 4,308,573 2023-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
THRD $14.30 64,617 Other 176,692 2024-10-29 Filing
THRD $14.30 396,963 Other 1,367,257 2024-10-29 Filing
THRD $14.30 538,420 Other 1,794,218 2024-10-29 Filing
MLTX $50.00 132,549 Large Shareholder, Director 1,287,768 2024-10-04 Filing
MLTX $50.00 836,862 Large Shareholder, Director 8,168,838 2024-10-04 Filing